Report cover image

Global Dimethyl Fumarate Delayed-release Capsules Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 07, 2025
Length 107 Pages
SKU # APRC20338998

Description

Summary

According to APO Research, The global Dimethyl Fumarate Delayed-release Capsules market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Dimethyl Fumarate Delayed-release Capsules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Dimethyl Fumarate Delayed-release Capsules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Dimethyl Fumarate Delayed-release Capsules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Dimethyl Fumarate Delayed-release Capsules include Teva Pharmaceutical, Sichuan Omnis Pharmaceutical, Qilu Pharmaceutical, Mylan, Polpharma, Neuraxpharm, Lupin, Hexal AG and Glenmark Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dimethyl Fumarate Delayed-release Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dimethyl Fumarate Delayed-release Capsules.

The Dimethyl Fumarate Delayed-release Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dimethyl Fumarate Delayed-release Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Dimethyl Fumarate Delayed-release Capsules Segment by Company

Teva Pharmaceutical
Sichuan Omnis Pharmaceutical
Qilu Pharmaceutical
Mylan
Polpharma
Neuraxpharm
Lupin
Hexal AG
Glenmark Pharmaceuticals
Cipla
Biogen
Accord Healthcare
Dimethyl Fumarate Delayed-release Capsules Segment by Type

120mg per Unit
240mg per Unit
Dimethyl Fumarate Delayed-release Capsules Segment by Application

Hospital and Clinic
Pharmacy
Other
Dimethyl Fumarate Delayed-release Capsules Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dimethyl Fumarate Delayed-release Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dimethyl Fumarate Delayed-release Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dimethyl Fumarate Delayed-release Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dimethyl Fumarate Delayed-release Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Dimethyl Fumarate Delayed-release Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

107 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Dimethyl Fumarate Delayed-release Capsules Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Dimethyl Fumarate Delayed-release Capsules Sales Estimates and Forecasts (2020-2031)
1.3 Dimethyl Fumarate Delayed-release Capsules Market by Type
1.3.1 120mg per Unit
1.3.2 240mg per Unit
1.4 Global Dimethyl Fumarate Delayed-release Capsules Market Size by Type
1.4.1 Global Dimethyl Fumarate Delayed-release Capsules Market Size Overview by Type (2020-2031)
1.4.2 Global Dimethyl Fumarate Delayed-release Capsules Historic Market Size Review by Type (2020-2025)
1.4.3 Global Dimethyl Fumarate Delayed-release Capsules Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Dimethyl Fumarate Delayed-release Capsules Sales Breakdown by Type (2020-2025)
1.5.2 Europe Dimethyl Fumarate Delayed-release Capsules Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Dimethyl Fumarate Delayed-release Capsules Sales Breakdown by Type (2020-2025)
1.5.4 South America Dimethyl Fumarate Delayed-release Capsules Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Dimethyl Fumarate Delayed-release Capsules Industry Trends
2.2 Dimethyl Fumarate Delayed-release Capsules Industry Drivers
2.3 Dimethyl Fumarate Delayed-release Capsules Industry Opportunities and Challenges
2.4 Dimethyl Fumarate Delayed-release Capsules Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Dimethyl Fumarate Delayed-release Capsules Revenue (2020-2025)
3.2 Global Top Players by Dimethyl Fumarate Delayed-release Capsules Sales (2020-2025)
3.3 Global Top Players by Dimethyl Fumarate Delayed-release Capsules Price (2020-2025)
3.4 Global Dimethyl Fumarate Delayed-release Capsules Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Dimethyl Fumarate Delayed-release Capsules Major Company Production Sites & Headquarters
3.6 Global Dimethyl Fumarate Delayed-release Capsules Company, Product Type & Application
3.7 Global Dimethyl Fumarate Delayed-release Capsules Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Dimethyl Fumarate Delayed-release Capsules Market CR5 and HHI
3.8.2 Global Top 5 and 10 Dimethyl Fumarate Delayed-release Capsules Players Market Share by Revenue in 2024
3.8.3 2023 Dimethyl Fumarate Delayed-release Capsules Tier 1, Tier 2, and Tier 3
4 Dimethyl Fumarate Delayed-release Capsules Regional Status and Outlook
4.1 Global Dimethyl Fumarate Delayed-release Capsules Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Dimethyl Fumarate Delayed-release Capsules Historic Market Size by Region
4.2.1 Global Dimethyl Fumarate Delayed-release Capsules Sales in Volume by Region (2020-2025)
4.2.2 Global Dimethyl Fumarate Delayed-release Capsules Sales in Value by Region (2020-2025)
4.2.3 Global Dimethyl Fumarate Delayed-release Capsules Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Dimethyl Fumarate Delayed-release Capsules Forecasted Market Size by Region
4.3.1 Global Dimethyl Fumarate Delayed-release Capsules Sales in Volume by Region (2026-2031)
4.3.2 Global Dimethyl Fumarate Delayed-release Capsules Sales in Value by Region (2026-2031)
4.3.3 Global Dimethyl Fumarate Delayed-release Capsules Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Dimethyl Fumarate Delayed-release Capsules by Application
5.1 Dimethyl Fumarate Delayed-release Capsules Market by Application
5.1.1 Hospital and Clinic
5.1.2 Pharmacy
5.1.3 Other
5.2 Global Dimethyl Fumarate Delayed-release Capsules Market Size by Application
5.2.1 Global Dimethyl Fumarate Delayed-release Capsules Market Size Overview by Application (2020-2031)
5.2.2 Global Dimethyl Fumarate Delayed-release Capsules Historic Market Size Review by Application (2020-2025)
5.2.3 Global Dimethyl Fumarate Delayed-release Capsules Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Dimethyl Fumarate Delayed-release Capsules Sales Breakdown by Application (2020-2025)
5.3.2 Europe Dimethyl Fumarate Delayed-release Capsules Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Dimethyl Fumarate Delayed-release Capsules Sales Breakdown by Application (2020-2025)
5.3.4 South America Dimethyl Fumarate Delayed-release Capsules Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Teva Pharmaceutical
6.1.1 Teva Pharmaceutical Comapny Information
6.1.2 Teva Pharmaceutical Business Overview
6.1.3 Teva Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Teva Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio
6.1.5 Teva Pharmaceutical Recent Developments
6.2 Sichuan Omnis Pharmaceutical
6.2.1 Sichuan Omnis Pharmaceutical Comapny Information
6.2.2 Sichuan Omnis Pharmaceutical Business Overview
6.2.3 Sichuan Omnis Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sichuan Omnis Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio
6.2.5 Sichuan Omnis Pharmaceutical Recent Developments
6.3 Qilu Pharmaceutical
6.3.1 Qilu Pharmaceutical Comapny Information
6.3.2 Qilu Pharmaceutical Business Overview
6.3.3 Qilu Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Qilu Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio
6.3.5 Qilu Pharmaceutical Recent Developments
6.4 Mylan
6.4.1 Mylan Comapny Information
6.4.2 Mylan Business Overview
6.4.3 Mylan Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mylan Dimethyl Fumarate Delayed-release Capsules Product Portfolio
6.4.5 Mylan Recent Developments
6.5 Polpharma
6.5.1 Polpharma Comapny Information
6.5.2 Polpharma Business Overview
6.5.3 Polpharma Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Polpharma Dimethyl Fumarate Delayed-release Capsules Product Portfolio
6.5.5 Polpharma Recent Developments
6.6 Neuraxpharm
6.6.1 Neuraxpharm Comapny Information
6.6.2 Neuraxpharm Business Overview
6.6.3 Neuraxpharm Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Neuraxpharm Dimethyl Fumarate Delayed-release Capsules Product Portfolio
6.6.5 Neuraxpharm Recent Developments
6.7 Lupin
6.7.1 Lupin Comapny Information
6.7.2 Lupin Business Overview
6.7.3 Lupin Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Lupin Dimethyl Fumarate Delayed-release Capsules Product Portfolio
6.7.5 Lupin Recent Developments
6.8 Hexal AG
6.8.1 Hexal AG Comapny Information
6.8.2 Hexal AG Business Overview
6.8.3 Hexal AG Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hexal AG Dimethyl Fumarate Delayed-release Capsules Product Portfolio
6.8.5 Hexal AG Recent Developments
6.9 Glenmark Pharmaceuticals
6.9.1 Glenmark Pharmaceuticals Comapny Information
6.9.2 Glenmark Pharmaceuticals Business Overview
6.9.3 Glenmark Pharmaceuticals Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Glenmark Pharmaceuticals Dimethyl Fumarate Delayed-release Capsules Product Portfolio
6.9.5 Glenmark Pharmaceuticals Recent Developments
6.10 Cipla
6.10.1 Cipla Comapny Information
6.10.2 Cipla Business Overview
6.10.3 Cipla Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Cipla Dimethyl Fumarate Delayed-release Capsules Product Portfolio
6.10.5 Cipla Recent Developments
6.11 Biogen
6.11.1 Biogen Comapny Information
6.11.2 Biogen Business Overview
6.11.3 Biogen Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Biogen Dimethyl Fumarate Delayed-release Capsules Product Portfolio
6.11.5 Biogen Recent Developments
6.12 Accord Healthcare
6.12.1 Accord Healthcare Comapny Information
6.12.2 Accord Healthcare Business Overview
6.12.3 Accord Healthcare Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Accord Healthcare Dimethyl Fumarate Delayed-release Capsules Product Portfolio
6.12.5 Accord Healthcare Recent Developments
7 North America by Country
7.1 North America Dimethyl Fumarate Delayed-release Capsules Sales by Country
7.1.1 North America Dimethyl Fumarate Delayed-release Capsules Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Dimethyl Fumarate Delayed-release Capsules Sales by Country (2020-2025)
7.1.3 North America Dimethyl Fumarate Delayed-release Capsules Sales Forecast by Country (2026-2031)
7.2 North America Dimethyl Fumarate Delayed-release Capsules Market Size by Country
7.2.1 North America Dimethyl Fumarate Delayed-release Capsules Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Dimethyl Fumarate Delayed-release Capsules Market Size by Country (2020-2025)
7.2.3 North America Dimethyl Fumarate Delayed-release Capsules Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Dimethyl Fumarate Delayed-release Capsules Sales by Country
8.1.1 Europe Dimethyl Fumarate Delayed-release Capsules Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Dimethyl Fumarate Delayed-release Capsules Sales by Country (2020-2025)
8.1.3 Europe Dimethyl Fumarate Delayed-release Capsules Sales Forecast by Country (2026-2031)
8.2 Europe Dimethyl Fumarate Delayed-release Capsules Market Size by Country
8.2.1 Europe Dimethyl Fumarate Delayed-release Capsules Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Dimethyl Fumarate Delayed-release Capsules Market Size by Country (2020-2025)
8.2.3 Europe Dimethyl Fumarate Delayed-release Capsules Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Dimethyl Fumarate Delayed-release Capsules Sales by Country
9.1.1 Asia-Pacific Dimethyl Fumarate Delayed-release Capsules Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Dimethyl Fumarate Delayed-release Capsules Sales by Country (2020-2025)
9.1.3 Asia-Pacific Dimethyl Fumarate Delayed-release Capsules Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Dimethyl Fumarate Delayed-release Capsules Market Size by Country
9.2.1 Asia-Pacific Dimethyl Fumarate Delayed-release Capsules Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Dimethyl Fumarate Delayed-release Capsules Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Dimethyl Fumarate Delayed-release Capsules Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Dimethyl Fumarate Delayed-release Capsules Sales by Country
10.1.1 South America Dimethyl Fumarate Delayed-release Capsules Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Dimethyl Fumarate Delayed-release Capsules Sales by Country (2020-2025)
10.1.3 South America Dimethyl Fumarate Delayed-release Capsules Sales Forecast by Country (2026-2031)
10.2 South America Dimethyl Fumarate Delayed-release Capsules Market Size by Country
10.2.1 South America Dimethyl Fumarate Delayed-release Capsules Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Dimethyl Fumarate Delayed-release Capsules Market Size by Country (2020-2025)
10.2.3 South America Dimethyl Fumarate Delayed-release Capsules Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Sales by Country
11.1.1 Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Sales by Country (2020-2025)
11.1.3 Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Market Size by Country
11.2.1 Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Dimethyl Fumarate Delayed-release Capsules Value Chain Analysis
12.1.1 Dimethyl Fumarate Delayed-release Capsules Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Dimethyl Fumarate Delayed-release Capsules Production Mode & Process
12.2 Dimethyl Fumarate Delayed-release Capsules Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Dimethyl Fumarate Delayed-release Capsules Distributors
12.2.3 Dimethyl Fumarate Delayed-release Capsules Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.